RIVM_Logo

Immunogenicity and safety of a hexavalent meningococcal outermembrane-vesicle vaccine in children of 2-3 and 7-8 years of age

 

Home / Documenten en publicaties / Immunogenicity and safety of a hexavalent meningococcal outermembrane-vesicle vaccine in children of 2-3 and 7-8 years of age

RIVM De zorg voor morgen begint vandaag
Menu